ISOCHEM S.A.S
ISOCHEM S.A.S (PMC Isochem) is a France-based pharmaceutical CDMO founded in 1974 that manufactures cGMP intermediates, generic APIs, excipients, and drug delivery polymers for pharmaceutical companies globally using specialized chemistry capabilities.
- Company typePrivate
- Founded1974
- HeadquartersVert-le-petit, France
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What ISOCHEM S.A.S does
ISOCHEM S.A.S, operating under the trade name PMC Isochem, is a France-based private pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Vert-le-Petit, founded in 1974. The company manufactures and markets intermediates, generic active pharmaceutical ingredients (APIs), excipients, and polymer-based drug delivery materials for pharmaceutical companies worldwide. Its technology platform centers on specialized chemical synthesis capabilities including phosgenation, hydrogenation, halogenation, cryogenic chemistry, and distillation, all operated under cGMP standards. Catalogue products include Vitamin E TPGS and polyamino acid-based drug delivery materials, NCA-UNCA compounds, cGMP intermediates, and anti-scratch varnishes, while custom services span end-to-end development and manufacturing for client drug pipelines.
The company generates revenue through project-based custom development and manufacturing contracts (CDMO services), direct sales of catalogue intermediates and APIs to pharmaceutical manufacturers, and contract research (CRO) services including analytical development and drug delivery/nanoformulation. Pricing is not publicly disclosed and is quote-based per project, consistent with B2B pharma CDMO norms. Go-to-market relies on direct enterprise field sales supported by an inquiry/application process on the corporate website, attendance at industry events such as DCAT Week (New York) and CHEM BIO Symposium (France), and downloadable technical resources. In January 2026 the company expanded into CRO activities specializing in analytical development and nanoformulation, and it previously broadened its footprint via the 2012 acquisition of Wychem Ltd.
ISOCHEM S.A.S firmographics
Firmographics- Name
- ISOCHEM S.A.S
- Legal name
- ISOCHEM S.A.S
- Website
- https://isochem.eu
- Company type
- Private
- Founded year
- 1974
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- ISOCHEM S.A.S (PMC Isochem) is a France-based pharmaceutical CDMO founded in 1974 that manufactures cGMP intermediates, generic APIs, excipients, and drug delivery polymers for pharmaceutical companies globally using specialized chemistry capabilities.
- Ownership category
- akta.pro rank
ISOCHEM S.A.S industry classification
Industry- Product category
- Pharmaceutical CDMO Services
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Small-Molecule API & Intermediates CDMO (HLAGABAA)
- akta.pro secondary industries
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
Keywords
Where ISOCHEM S.A.S is headquartered
LocationHeadquarters
- HQ city
- Vert-le-petit
- HQ country
- France
- HQ region
- Europe
Markets served
ISOCHEM S.A.S business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Custom Development and Manufacturing (CDMO) Services: Provides custom development and manufacturing services to pharmaceutical companies for intermediates, APIs, excipients, and polymers. Revenue is generated through project-based contracts with pharmaceutical clients for drug development and manufacturing.
- Catalogue Products: Sale of catalogue products including cGMP Intermediates, Generic APIs, Drug delivery materials (Vitamin E TPGS, Polyamino acids), NCA-UNCA compounds, and Anti-scratch varnishes. Products are sold to pharmaceutical manufacturers.
- Contract Research Services: CRO services including analytical services and drug delivery services for pharmaceutical research and development.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
ISOCHEM S.A.S product offering
Product offeringCore offering
ISOCHEM S.A.S (operating as PMC Isochem) is a France-based Contract Development and Manufacturing Organization (CDMO) for the global pharmaceutical industry. It manufactures and markets cGMP intermediates, generic Active Pharmaceutical Ingredients (APIs), excipients, and specialty polymers for drug delivery, and provides custom chemical synthesis, contract research (CRO) analytical services, and drug delivery/nanoformulation services.
Product overview
PMC Isochem operates as a Custom Development & Manufacturing Organization (CDMO) offering a portfolio of catalogue products and contract services. The product portfolio includes cGMP Intermediates, Generic Active Pharmaceutical Ingredients (APIs), Excipients, and Polymers for drug delivery solutions. Key drug delivery materials include Vitamin E TPGS and Polyamino acids. The company also offers specialty products such as NCA-UNCA compounds and anti-scratch varnishes. Services include custom development and manufacturing, research & development, quality assurance & regulatory support, and newly launched CRO services specializing in analytical development and nanoformulation.
Differentiator
Problem solved
Functional benefit
Products and services
- Vitamin E TPGS Vitamin E TPGS (d-alpha-tocopheryl polyethylene glycol 1000 succinate) is a proprietary drug delivery material sold as an excipient for pharmaceutical formulations.
- Polyamino acids Polymer-based drug delivery materials (polyamino acids) for pharmaceutical applications, offered as catalogue products.
- Generic APIs Generic Active Pharmaceutical Ingredients manufactured and sold as catalogue products to pharmaceutical companies.
- cGMP Intermediates cGMP-compliant intermediates manufactured for pharmaceutical applications and sold as catalogue products.
- NCA - UNCA NCA (N-Carboxyanhydride) and UNCA (Urethane N-Carboxyanhydride) chemical compounds offered as specialty catalogue products.
- Anti-scratch varnishes Specialty anti-scratch varnish products sold as catalogue offerings.
- Custom Development and Manufacturing (CDMO) Project-based custom development and manufacturing services for pharmaceutical intermediates and APIs under cGMP.
- Research & Development Research and development services supporting pharmaceutical development and process optimization.
- CRO Analytical Services Contract research analytical services for pharmaceutical analysis, formally launched as part of the company's CRO offering expansion.
- CRO Drug Delivery Services Contract research drug delivery services including nanoformulation, formally launched as part of the company's CRO offering expansion.
Companies that use ISOCHEM S.A.S
Customer profileSegments1 record
Ideal customer profiles1 record
ISOCHEM S.A.S technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature9 records
ISOCHEM S.A.S partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights4 records
ISOCHEM S.A.S competitors and assessment
Company assessmentBroad incumbents
- Siegfried Holding: Siegfried is a Swiss-headquartered pharmaceutical CDMO focused on small-molecule APIs and finished drug products. Overlaps directly with PMC Isochem's CDMO scope and serves the same pharmaceutical customer base, but at significantly larger scale.
- WuXi STA (WuXi AppTec): WuXi STA is a leading global small-molecule API and intermediates CDMO in China with a broad service portfolio. Competes with PMC Isochem for the same pharmaceutical customers, particularly those seeking custom synthesis at scale.
- Lonza Group: Lonza is the world's largest pharmaceutical CDMO with comprehensive small-molecule API, intermediate, and drug product services. Comparable to PMC Isochem in offering CDMO services, but operates at vastly greater scale with a global multi-site footprint.
- Johnson Matthey (Health sector): Johnson Matthey's Health division offers pharmaceutical API and fine chemicals CDMO services, including complex chemistry. Comparable to PMC Isochem's complex synthesis and intermediates focus, but as part of a much larger diversified group.
Direct peers
- Novasep: Novasep is a French-headquartered CDMO specializing in complex small-molecule APIs, purification, and chromatography services. Comparable to PMC Isochem by French base, CDMO focus, and specialization in complex chemistry.
- Fareva: Fareva operates pharmaceutical CDMO manufacturing facilities in France and Europe, providing APIs, intermediates, and finished dosage forms. Closely comparable business model and French/European manufacturing footprint to PMC Isochem.
- Cambrex (acquired by Permira): Cambrex is a US/EU-based small-molecule API and intermediates CDMO with specialized chemistry capabilities. Directly comparable to PMC Isochem in service offering, customer base, and project-based CDMO model.
- SEQENS (formerly Novacap): SEQENS is a French-based pharmaceutical CDMO and specialty chemicals manufacturer offering custom synthesis, APIs, intermediates, and excipients. Directly comparable to PMC Isochem by geography (France), scale, and service portfolio across CDMO and pharmaceutical ingredients.
Emerging players
- PolyPeptide Group: PolyPeptide is a specialty CDMO focused on peptides and related complex chemistries. Comparable to PMC Isochem in serving pharma customers with custom synthesis, though specializing in a different molecule class.
- Eurofins CDMO (formerly Amatsigroup): Eurofins' CDMO arm (built on Amatsigroup) offers French-based pharmaceutical development and manufacturing services including analytical support. Comparable to PMC Isochem's newly launched CRO analytical and CDMO services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
ISOCHEM S.A.S social profiles
Digital presenceISOCHEM S.A.S financial estimates
Financial estimateRevenue estimate
Valuation estimate
ISOCHEM S.A.S leadership team
Management profileNumber of profiles
ISOCHEM S.A.S funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ISOCHEM S.A.S M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ISOCHEM S.A.S
What does ISOCHEM S.A.S do?
ISOCHEM S.A.S (operating as PMC Isochem) is a France-based Contract Development and Manufacturing Organization (CDMO) for the global pharmaceutical industry. It manufactures and markets cGMP intermediates, generic Active Pharmaceutical Ingredients (APIs), excipients, and specialty polymers for drug delivery, and provides custom chemical synthesis, contract research (CRO) analytical services, and drug delivery/nanoformulation services.
Is ISOCHEM S.A.S a public or private company?
ISOCHEM S.A.S is a private company. It is classified as unknown and is currently operating.
When was ISOCHEM S.A.S founded?
ISOCHEM S.A.S was founded in 1974. It employs 251 to 500 people.
Where is ISOCHEM S.A.S based?
ISOCHEM S.A.S is headquartered in Vert-le-petit, France, in the Europe region.
How does ISOCHEM S.A.S make money?
Three revenue lines are on record. Custom Development and Manufacturing (CDMO) Services are the primary driver. The others are catalogue Products and contract Research Services.
Who are ISOCHEM S.A.S's main competitors?
Broad incumbents on record are Siegfried Holding, WuXi STA (WuXi AppTec), Lonza Group and Johnson Matthey (Health sector). Direct peers are Novasep, Fareva, Cambrex (acquired by Permira) and SEQENS (formerly Novacap). Emerging players are PolyPeptide Group and Eurofins CDMO (formerly Amatsigroup).
Does ISOCHEM S.A.S have an API?
No public API is recorded for ISOCHEM S.A.S.
What industry is ISOCHEM S.A.S in?
ISOCHEM S.A.S's product category is Pharmaceutical CDMO Services. Its primary akta.pro industry code is HLAGABAA, Small-Molecule API & Intermediates CDMO, with a secondary code of HLAGABAG, Drug Substance–Drug Product Integrated CDMO. Its NAICS code is 325412 and its SIC code is 2834.